QUIDELORTHO CORP Acquisitions, Net of Cash Acquired
QUIDELORTHO CORP (QDEL) reported Acquisitions, Net of Cash Acquired of $96.80 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-08-07
- QUIDELORTHO CORP payments to acquire businesses, net of cash acquired for the quarter ending 2023-12-31 was $0.00.
- QUIDELORTHO CORP payments to acquire businesses, net of cash acquired for the quarter ending 2023-10-01 was $0.00.
- QUIDELORTHO CORP payments to acquire businesses, net of cash acquired for the quarter ending 2023-01-01 was $0.00.
- QUIDELORTHO CORP payments to acquire businesses, net of cash acquired for the quarter ending 2022-10-02 was $0.00.
- QUIDELORTHO CORP payments to acquire businesses, net of cash acquired for fiscal 2024 was $0.00.
- QUIDELORTHO CORP payments to acquire businesses, net of cash acquired for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2023.
- QUIDELORTHO CORP payments to acquire businesses, net of cash acquired for fiscal 2023 was $1.51B.
- QUIDELORTHO CORP payments to acquire businesses, net of cash acquired for fiscal 2022 was $0.00.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2026-06-28 | $96.80M 10-Q · filed 2026-08-07 | |||
| 2025-06-29 | $0.00 10-Q · filed 2026-08-07 | |||
| 2024-12-29 | $0.00 10-K · filed 2025-02-27 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | |
| 2023-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | ||
| 2023-07-02 | $0.00 10-Q · filed 2023-08-09 | |||
| 2023-01-01 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $1.51B 10-K · filed 2025-02-27 | |
| 2022-10-02 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.51B 10-Q · filed 2023-11-02 | ||
| 2022-07-03 | $1.51B 10-Q · filed 2023-08-09 | |||
| 2022-01-02 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $0.00 derived: sum of 2 quarters · filed 2024-08-01 | $0.00 10-K/A · filed 2024-08-01 | |
| 2021-10-03 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | ||
| 2021-07-04 | $0.00 10-Q · filed 2022-08-05 | |||
| 2021-01-03 | $0.00 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |